MedTrace Logo

Pneumococcal Community-Acquired Pneumonia Requiring Hospitalization Among Colombian Adults

NCT07354425 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 688

Last updated 2026-01-21

No results posted yet for this study

Summary

Pneumococcal Community-Acquired Pneumonia Requiring Hospitalization Among Adults in Colombia (Pneumo-CAP Colombia)

This study aims to learn more about pneumococcal community-acquired pneumonia (CAP) caused by Streptococcus pneumoniae among adults hospitalized in 11 hospitals in the Sabana Centro region of Colombia. The study will describe the characteristics of adults with CAP, estimate pneumococcal CAP prevalence in the area, and examine the specific serotypes of S. pneumoniae causing this infection. This research is essential for understanding which microorganism is the most prevalent cause of CAP in the region, whether pneumococcal vaccines included in governmental vaccination programs protect adults, which specific pneumococcal serotypes are circulating, and which available vaccine will best protect people against pneumococcal CAP.

The study will be conducted at 11 hospitals in the Sabana Centro region and will collect data over 2 years. The study will gather detailed information on each patient's condition, including symptoms, medical history, and outcomes such as death or the need for intensive care.

Conditions

  • Community Acquired Pneumonia (CAP)
  • Pneumococcal Pneumonia

Sponsors & Collaborators

  • Clínica Universidad de La Sabana

    collaborator UNKNOWN

  • Universidad de La Sabana, Colombia

    collaborator UNKNOWN

  • Universidad de la Sabana

    lead OTHER

Principal Investigators

  • Luis F Reyes, MD,PhD, MsC · Universidad de la Sabana

  • Cristian C Serrano, MD, cPhD · Clinica Universidad de La Sabana

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-28
Primary Completion
2025-02-25
Completion
2025-02-25

Countries

  • Colombia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07354425 on ClinicalTrials.gov